SMPL Update, Form-4 Alert


The Simply Good Foods Co. SMPL – 
Options Review 
.
On Thursday morning, SMPL was among the fresh options trading targets that we had mentioned in our premarket report.  We were looking specifically at the SMPL 08/21 $20-22.50 Calls.

Despite it being one of our relatively rare longer-term swing-trade ideas, with tons of time remaining until expiration, we did see some early gains right off the bat from those plays as the week drew to a close.

08/21 $20-22.50 Calls
$20: 1.50-2.20 (+47%)
$22.50: .70-1.30 (+86%)

We’ll certainly continue to have these targets on watch in the weeks and months ahead, it was good to see some instantaneous opportunity arise.
_____

Fresh Ideas: 
SPY Weekly $284-286 Calls 


AxoGen Inc. AXGN – Form-4 Alert

We would also like to make mention of AXGN this morning. which we caught sight of during a routine Form-4 scan. We’ve got the CEO picking up shares and adding to his already considerable position just as the stock was preparing to register new annual lows.

We generally like to put stocks in this situation on watch, and will be anxiously awaiting the company’s quarterly results due in roughly two weeks.


Extended Watchlist:
DMAN, KNOS, PCTL, OWCP, HUTMF, NBY, AVCT, EROS, CYCC, TRNX,

Incredible Options Trading Week!

Another Big Options Trading Week

UnitedHealth Group, Inc. UNH – We were just reporting on the solid gains made by our UNH idea yesterday, the UNH Weekly $270-277.50 Calls. It was a see-saw kind of a day for the markets at large, but there was still plenty of opportunity for us to increase our observed ranges on these plays since we began tracking them Wednesday morning:

UNH Weekly $270-277.50 Calls

$270: 6.00-26.50 (+342%)
$272.50: 4.21-26.00 (+518%)
$275: 3.30-20.00 (+506%)
$277.50: 2.39-21.40 (+795%)

_____

Johnson & Johnson JNJ –  We’ve also been following the JNJ 09/18 $150-155 Calls since last Tuesday morning, and like the play above, are returning for the second straight day to highlight the impressive gains we’ve witnessed thus far:

  JNJ 09/18 $150-155 Calls
$150: 2.90-10.17 (+251%)
$155: 2.27-7.50 (+230%)
____

The success with our options calls just kept coming this week, and that includes a pair of our ideas that were fresh for yesterday morning. We signaled interest in calls in the ABT and TSM chains, and saw some really nice moves there as well.

ABT Weekly $90-92.50 Calls
$90: 2.00-7.10 (+255%)
$92.50: .85-5.00 (+488%)
_____

TSM Weekly $50-52 Calls
$50: 1.86-3.16 (+70%)
$50.50:1.55-2.50 (+61%)
$51: 1.30-2.15 (+65%)
$51.50: .57-1.70 (+198%)
$52: .65-1.26 (+94%)

_____

More Fresh Ideas: 
STT Weekly $60-65 Calls*
KSU Weekly $136-140 Calls*

*Never trade options with a weekly expiration on Friday unless you’re an expert level trader with access to disposable funds!


Moderna Inc. MRNA

We began tracking MRNA at the end of February, initially tagging the stock on February 27th and then again on March 16th. After seeing a low of 19.31 following that report, MRNA has been making steady headway in its run up the chart which has persisted for more than a month now.

Yesterday we saw a new recorded high of 41.55, which represents an overall increase of 115% since we began following the activity in MRNA.


Extended Watchlist:
CBDL, TURV, CNBX, DECN, GLGI, PWRMF, SBES, PCTL

Coronavirus Watchlist & More

Todos Medical, Ltd. TOMDF

The see-saw of market volatility persists with no end in sight. Traditional investing has become a fool’s errand in many, if not most, cases. The kind of opportunistic short term trading that we do is relatively intact, with the right targets and scenarios.

In this case, we caught TOMDF’s coronavirus news in the premarket yesterday, stating that the company had secured distribution agreements for testing kits in both the US and Isreal. After including it in our extended watchlist, the stock managed a very nice intraday gain. It traded up from a low of  0413, and reached a high of .08, which works out to an intraday upswing of 94%


Coronavirus Watchlist

While we do focus primarily on quick strike opportunities, it’s also worth it to mention a few plays that represent products and services that are high demand at the present time due to the fallout from COVID-19. If the report from the UK’s highly respected Imperial College is accurate, this global health crisis is only in its beginning stages, and will get much, much worse in the months ahead.

While neither these, nor any other plays are “corona-proof”, the effects may weigh less heavily on these stocks and those like them:

CPB, APRN, CLX, GIS, PG


Extended Watchlist:
MATN, ZOOM, DECN, PCTL, NBDR, IPIX, GNPX, GNBT